Key takeaways from ISPOR Europe 2023

Key takeaways from ISPOR Europe 2023

ISPOR Europe was the busiest we’ve ever seen it. Those few days were jam-packed with engaging plenary sessions, educational symposia, poster research, and networking opportunities. Many fruitful conversations were had, with the team contributing the following rundown...
The power of trial interviews

The power of trial interviews

In October 2023, the US Food and Drug Administration (FDA) released their industry guidance for benefit-risk assessment of novel products¹, in which the role of patient experience data was highlighted in its capacity to “inform nearly every aspect of FDA’s...
ISOQOL 30th Annual Conference take-aways

ISOQOL 30th Annual Conference take-aways

The International Society for Quality of Life Research (ISOQOL) 30th Annual Conference took place last month in Calgary, providing the opportunity for researchers, healthcare professionals, industry representatives, and patient research partners to explore the use of...
ISPOR EU 2023

ISPOR EU 2023

ISPOR Europe is on the horizon and we’ll be exhibiting four posters at stand C2-027, and Mark Larkin, CEO, will be speaking at an educational symposium. This year’s conference will focus on the role of health economics and outcomes research science in shaping policy –...
Skip to content